AI generated
Jun 21, 2026, 07:50
Pallavi Madhiraju: Evategrel Shows Promise for Rapid and Consistent Platelet Inhibition
Pallavi Madhiraju, Owner of Cricket Herald, shared a post on LinkedIn:
“Discover whether Cure Gene’s evategrel can overcome clopidogrel variability and deliver rapid platelet inhibition without increasing bleeding risk.”
Stay updated with Hemostasis Today.
-
Jun 21, 2026, 08:44Patient Experience Sheds Light on Complexities of Antithrombotic Care in APS – APS Foundation of America
-
Jun 21, 2026, 08:04Phil Ambery: Next-Generation Endothelin Therapeutics Renew Interest in a Proven Pathway
-
Jun 21, 2026, 07:39Heghine Khachatryan: Emerging Evidence Links NET Formation to Thrombosis and Disease Progression in Gynecologic Malignancies
-
Jun 21, 2026, 07:24Seema Dawood: The Power of Blood Smear Confirmation in Detecting Immature Granulocytes
-
Jun 21, 2026, 05:32Flora Peyvandi: Characterizing Acquired VWD Through a Large Patient Cohort
-
Jun 21, 2026, 05:23Mohammed Alo: The Gap Between Nattokinase Marketing and Evidence
-
Jun 21, 2026, 05:11Selma Turkovic: Blood Transfusion Education and Discussion Group Webinar N63
-
Jun 21, 2026, 04:00X. Long Zheng: New Findings on ADAMTS13 in Hemostasis and Thrombosis
-
Jun 21, 2026, 03:04Mauricio Vasco Ramirez: Balancing Bleeding and Thrombotic Risks in Ultrasound-Guided Intervention